Favorites Sign in
  1. Home
  2. Companies
  3. Stock PMV Pharmaceuticals
PMV Pharmaceuticals logo

PMV Pharmaceuticals PMVP

$ 1.15 -9.45%
report update icon

Quarterly report 2026-Q1
added 05-12-2026

Country

 usaUSA

IPO year

 2020

Industry

 Biotechnology

Stock Exchange

 NASDAQ GLOBAL

Shares

 52.5 M

Market Cap[1]

 $ 60.4 M

EBITDA (LTM)

 $ -86.1 M

P/E (LTM)

 -0.871622

P/S (LTM)

 -

EPS (LTM)

 -1.48

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
Reata Pharmaceuticals Reata Pharmaceuticals
RETA
 		- - $ 6.29 B Nasdaq Global Market,SPB usaUSA
ObsEva SA ObsEva SA
OBSV
 		- -15.52 % $ 10.5 M Nasdaq Global Select Market schweizSchweiz
PolarityTE PolarityTE
PTE
 		- -0.82 % $ 1.78 M Nasdaq Capital Market usaUSA
Kronos Bio Kronos Bio
KRON
 		- 1.49 % $ 50.8 M Nasdaq Global Select Market usaUSA
Landos Biopharma Landos Biopharma
LABP
 		- 0.58 % $ 144 M Nasdaq Global Market usaUSA
Myovant Sciences Ltd. Myovant Sciences Ltd.
MYOV
 		- -0.04 % $ 2.62 B NYSE usaUSA
Poseida Therapeutics Poseida Therapeutics
PSTX
 		- - $ 857 M Nasdaq Global Select Market usaUSA
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
 		- - $ 231 M Nasdaq Global Market usaUSA
Trevena Trevena
TRVN
 		- -46.58 % $ 31.8 M Nasdaq Capital Market usaUSA
Virpax Pharmaceuticals Virpax Pharmaceuticals
VRPX
 		- -45.12 % $ 2.85 M Nasdaq Global Select Market usaUSA
Oncorus Oncorus
ONCR
 		- -8.54 % $ 3.19 M Nasdaq Global Market usaUSA
Y-mAbs Therapeutics Y-mAbs Therapeutics
YMAB
 		- - $ 382 M Nasdaq Global Select Market,SPB usaUSA
Navidea Biopharmaceuticals Navidea Biopharmaceuticals
NAVB
 		- -2.99 % $ 2.47 M NYSE American usaUSA
Stealth BioTherapeutics Corp Stealth BioTherapeutics Corp
MITO
 		- - $ 23.9 M Nasdaq Global Select Market usaUSA
Acer Therapeutics Acer Therapeutics
ACER
 		- 2.71 % $ 14 M Nasdaq Capital Market usaUSA
Satsuma Pharmaceuticals Satsuma Pharmaceuticals
STSA
 		- -0.9 % $ 36.5 M Nasdaq Global Market usaUSA
Anavex Life Sciences Corp. Anavex Life Sciences Corp.
AVXL
 		$ 1.29 -3.38 % $ 110 M Nasdaq Capital Market usaUSA
SpringWorks Therapeutics SpringWorks Therapeutics
SWTX
 		- - $ 3.48 B Nasdaq Global Select Market,SPB usaUSA
Metacrine Metacrine
MTCR
 		- - $ 24.2 M Nasdaq Global Select Market usaUSA
Turning Point Therapeutics Turning Point Therapeutics
TPTX
 		- -0.13 % $ 3.73 B Nasdaq Global Select Market,SPB usaUSA
Infinity Pharmaceuticals Infinity Pharmaceuticals
INFI
 		- -46.98 % $ 3.57 M Nasdaq Global Select Market usaUSA
OncoSec Medical Incorporated OncoSec Medical Incorporated
ONCS
 		- 31.87 % $ 1.61 M Nasdaq Global Select Market usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
 		- - $ 7.46 M Nasdaq Global Market israelIsrael
Evelo Biosciences Evelo Biosciences
EVLO
 		- -14.46 % $ 27.9 M Nasdaq Global Select Market usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
 		- -4.8 % $ 255 M Nasdaq Global Select Market usaUSA
Morphic Holding Morphic Holding
MORF
 		- - $ 2.42 B Nasdaq Global Market usaUSA
Novan Novan
NOVN
 		- -24.84 % $ 2.64 M Nasdaq Capital Market usaUSA
Genocea Biosciences Genocea Biosciences
GNCA
 		- -15.0 % $ 3.04 M Nasdaq Global Select Market usaUSA
Equillium Equillium
EQ
 		$ 1.23 -0.41 % $ 70.5 M Nasdaq Global Market usaUSA
Eiger BioPharmaceuticals Eiger BioPharmaceuticals
EIGR
 		- -9.21 % $ 2.55 M Nasdaq Global Market usaUSA
Albireo Pharma Albireo Pharma
ALBO
 		- -0.23 % $ 916 M Nasdaq Capital Market usaUSA
BELLUS Health BELLUS Health
BLU
 		- - $ 2.47 B Nasdaq Global Select Market canadaCanada
bluebird bio bluebird bio
BLUE
 		- - $ 546 M Nasdaq Global Select Market,SPB usaUSA
Intra-Cellular Therapies Intra-Cellular Therapies
ITCI
 		- - $ 13.6 B Nasdaq Global Select Market,SPB usaUSA
IGM Biosciences IGM Biosciences
IGMS
 		- - $ 76.9 M Nasdaq Global Select Market,SPB usaUSA
Marinus Pharmaceuticals Marinus Pharmaceuticals
MRNS
 		- - $ 29.6 M Nasdaq Global Select Market usaUSA
Merrimack Pharmaceuticals Merrimack Pharmaceuticals
MACK
 		- - $ 216 M Nasdaq Global Market usaUSA
CASI Pharmaceuticals CASI Pharmaceuticals
CASI
 		- - $ 35.4 M Nasdaq Capital Market usaUSA
ContraFect Corporation ContraFect Corporation
CFRX
 		- -5.16 % $ 5.39 M Nasdaq Capital Market usaUSA
Sigilon Therapeutics Sigilon Therapeutics
SGTX
 		- - $ 728 M Nasdaq Global Select Market usaUSA
Rubius Therapeutics Rubius Therapeutics
RUBY
 		- -33.55 % $ 7.81 M Nasdaq Global Select Market usaUSA
Aptinyx Aptinyx
APTX
 		- -39.0 % $ 4.57 M Nasdaq Global Select Market usaUSA
TRACON Pharmaceuticals TRACON Pharmaceuticals
TCON
 		- -1.38 % $ 46.8 M Nasdaq Capital Market usaUSA
Edesa Biotech Edesa Biotech
EDSA
 		$ 2.56 -7.58 % $ 14.5 M Nasdaq Capital Market usaUSA
Greenwich LifeSciences Greenwich LifeSciences
GLSI
 		$ 17.42 8.67 % $ 236 M Nasdaq Capital Market usaUSA
Mirati Therapeutics Mirati Therapeutics
MRTX
 		- - $ 3.3 B Nasdaq Global Select Market,SPB usaUSA
Revance Therapeutics Revance Therapeutics
RVNC
 		- - $ 309 M Nasdaq Global Select Market usaUSA
InVivo Therapeutics Holdings Corp. InVivo Therapeutics Holdings Corp.
NVIV
 		- -37.48 % $ 476 K Nasdaq Capital Market usaUSA
Epizyme Epizyme
EPZM
 		- - $ 249 M Nasdaq Global Select Market usaUSA
Bellicum Pharmaceuticals Bellicum Pharmaceuticals
BLCM
 		- -9.72 % $ 5.89 M Nasdaq Capital Market usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.